Literature DB >> 27795443

JunD/AP-1 Antagonizes the Induction of DAPK1 To Promote the Survival of v-Src-Transformed Cells.

Bart M Maślikowski1, Lizhen Wang1, Ying Wu1, Ben Fielding1, Pierre-André Bédard2.   

Abstract

The increase in AP-1 activity is a hallmark of cell transformation by tyrosine kinases. Previously, we reported that blocking AP-1 using the c-Jun dominant negative mutant TAM67 induced senescence, adipogenesis, or apoptosis in v-Src-transformed chicken embryo fibroblasts (CEFs) whereas inhibition of JunD by short hairpin RNA (shRNA) specifically induced apoptosis. To investigate the role of AP-1 in Src-mediated transformation, we undertook a gene profiling study to characterize the transcriptomes of v-Src-transformed CEFs expressing either TAM67 or the JunD shRNA. Our study revealed a cluster of 18 probe sets upregulated exclusively in response to AP-1/JunD impairment and v-Src transformation. Four of these probe sets correspond to genes involved in the interferon pathway. One gene in particular, death-associated protein kinase 1 (DAPK1), is a C/EBPβ-regulated mediator of apoptosis in gamma interferon (IFN-γ)-induced cell death. Here, we show that inhibition of DAPK1 abrogates cell death in v-Src-transformed cells expressing the JunD shRNA. Chromatin immunoprecipitation data indicated that C/EBPβ was recruited to the DAPK1 promoter while the expression of a dominant negative mutant of C/EBPβ abrogated the induction of DAPK1 in response to the inhibition of AP-1. In contrast, as determined by chromatin immunoprecipitation (ChIP) assays, JunD was not detected on the DAPK1 promoter under any conditions, suggesting that JunD promotes survival by indirectly antagonizing the expression of DAPK1 in v-Src transformed cells. IMPORTANCE: Transformation by the v-Src oncoprotein causes extensive changes in gene expression in primary cells such as chicken embryo fibroblasts. These changes, determining the properties of transformed cells, are controlled in part at the transcriptional level. Much attention has been devoted to transcription factors such as AP-1 and NF-κB and the control of genes associated with a more aggressive phenotype. In this report, we describe a novel mechanism of action determined by the JunD component of AP-1, a factor enhancing cell survival in v-Src-transformed cells. We show that the loss of JunD results in the aberrant activation of a genetic program leading to cell death. This program requires the activation of the tumor suppressor death-associated protein kinase 1 (DAPK1). Since DAPK1 is phosphorylated and inhibited by v-Src, these results highlight the importance of this kinase and the multiple mechanisms controlled by v-Src to antagonize the tumor suppressor function of DAPK1.
Copyright © 2016 American Society for Microbiology.

Entities:  

Keywords:  AP-1; C/EBPβ; DAPK1; JunD; transformation; v-Src

Mesh:

Substances:

Year:  2016        PMID: 27795443      PMCID: PMC5165225          DOI: 10.1128/JVI.01925-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.

Authors:  J T Bruder; G Heidecker; U R Rapp
Journal:  Genes Dev       Date:  1992-04       Impact factor: 11.361

Review 2.  The death-associated protein kinases: structure, function, and beyond.

Authors:  Shani Bialik; Adi Kimchi
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  CCAAT/enhancer-binding protein-beta regulates interferon-induced transcription through a novel element.

Authors:  S K Roy; S J Wachira; X Weihua; J Hu; D V Kalvakolanu
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

4.  C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements.

Authors:  M Vallejo; D Ron; C P Miller; J F Habener
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

5.  Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors.

Authors:  R Karni; R Jove; A Levitzki
Journal:  Oncogene       Date:  1999-08-19       Impact factor: 9.867

6.  Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression.

Authors:  D-W Wu; T-C Wu; J-Y Wu; Y-W Cheng; Y-C Chen; M-C Lee; C-Y Chen; H Lee
Journal:  Oncogene       Date:  2013-10-07       Impact factor: 9.867

7.  Activating SRC mutation in a subset of advanced human colon cancers.

Authors:  R B Irby; W Mao; D Coppola; J Kang; J M Loubeau; W Trudeau; R Karl; D J Fujita; R Jove; T J Yeatman
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

8.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region.

Authors:  W Hsu; T K Kerppola; P L Chen; T Curran; S Chen-Kiang
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

10.  JunD reduces tumor angiogenesis by protecting cells from oxidative stress.

Authors:  Damien Gerald; Edurne Berra; Yves M Frapart; Denise A Chan; Amato J Giaccia; Daniel Mansuy; Jacques Pouysségur; Moshe Yaniv; Fatima Mechta-Grigoriou
Journal:  Cell       Date:  2004-09-17       Impact factor: 41.582

View more
  4 in total

Review 1.  A Tale of Two States: Normal and Transformed, With and Without Rigidity Sensing.

Authors:  Michael Sheetz
Journal:  Annu Rev Cell Dev Biol       Date:  2019-08-14       Impact factor: 13.827

2.  Transregulation of microRNA miR-21 promoter by AP-1 transcription factor in cervical cancer cells.

Authors:  Sacnite Del Mar Díaz-González; Eduardo Daniel Rodríguez-Aguilar; Angélica Meneses-Acosta; Viviana Valadez-Graham; Jessica Deas; Claudia Gómez-Cerón; Carlos Alberto Tavira-Montalván; Alitzel Arizmendi-Heras; Julián Ramírez-Bello; Mario Enrique Zurita-Ortega; Berenice Illades-Aguiar; Marco Antonio Leyva-Vázquez; Gloria Fernández-Tilapa; Víctor Hugo Bermúdez-Morales; Vicente Madrid-Marina; Mauricio Rodríguez-Dorantes; Carlos Pérez-Plasencia; Oscar Peralta-Zaragoza
Journal:  Cancer Cell Int       Date:  2019-08-15       Impact factor: 5.722

3.  Tumor Suppressor DAPK1 Catalyzes Adhesion Assembly on Rigid but Anoikis on Soft Matrices.

Authors:  Ruifang Qin; Shay Melamed; Bo Yang; Mayur Saxena; Michael P Sheetz; Haguy Wolfenson
Journal:  Front Cell Dev Biol       Date:  2022-07-19

4.  The Role of Autophagy in Tumor Immune Infiltration in Colorectal Cancer.

Authors:  Yu Bian-Fang; Wu Dong-Ning; Teng Dan; Shi Jian-Yu; Wang Shi-Yi; Wang Ben-Jun; Dong Xin; Zhao Wen-Wen; Wang Qing-Feng; Zhao Yan
Journal:  Anal Cell Pathol (Amst)       Date:  2022-03-14       Impact factor: 2.916

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.